
|Articles|August 15, 2004
Glaucoma drug may be useful approach for blepharospasm
Monterey Park, CA-Latanoprost (Xalatan, Pfizer) may be an alternative treatment for blepharospasm. Ted C. Wei Jr., MD, reported that 75% of his patients had moderate to complete resolution of symptoms after latanoprost was prescribed.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR Surgical terminates proposed acquisition by Alcon
2
FDA grants Breakthrough Therapy Designation to Oculis’ privosegtor for optic neuritis
3
Rates of retinal layer thinning predict visual field progression in glaucoma
4
International meta-analysis highlights elevated ocular risk in Clade I Monkeypox
5












































